Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30633
Abstract: Patients with carcinoid tumors frequently could benefit from the pharmacologic treatment of depression and anxiety. However, many prescribers avoid serotonergic medications due to the theoretical risk of exacerbating carcinoid syndrome. read more here.
Keywords: review serotonergic; medication tolerability; carcinoid syndrome; tolerability patients ... See more keywords
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Gastrointestinal Cancer"
DOI: 10.1007/s12029-020-00375-2
Abstract: Background Telotristat ethyl is approved to treat carcinoid syndrome diarrhea in combination with somatostatin analogs. In TELESTAR and TELECAST phase III studies, patients with carcinoid syndrome received telotristat ethyl 250 or 500 mg 3 times per… read more here.
Keywords: frequency; telotristat ethyl; time; carcinoid syndrome ... See more keywords
Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection
Sign Up to like & getrecommendations! Published in 2019 at "Surgery"
DOI: 10.1016/j.surg.2018.09.008
Abstract: Background: The incidence, clinical characteristics, and long‐term outcomes of patients with gastroenteropancreatic neuroendrocrine tumors and carcinoid syndrome undergoing operative resection have not been well characterized. Methods: Patients undergoing resection of primary or metastatic gastroenteropancreatic neuroendrocrine… read more here.
Keywords: resection; carcinoid syndrome; operative resection; undergoing operative ... See more keywords
Carcinoid Syndrome in a Patient with Duodenal Carcinoid Tumor
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Research"
DOI: 10.11648/j.crj.20210903.15
Abstract: Duodenal carcinoid tumors accounts for 5% of all Gastrointestinal Neuroendocrine Tumors (GI-NETs). Only 4% of all duodenal carcinoid tumors present with a full-blown carcinoid syndrome. We report a case of duodenal carcinoid tumor presenting as… read more here.
Keywords: duodenal carcinoid; carcinoid tumor; carcinoid tumors; carcinoid syndrome ... See more keywords
Association between duration of somatostatin analogs (SSAs) use and quality of life in patients with carcinoid syndrome in the United States based on the FACT-G instrument.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e15693
Abstract: e15693Background: Carcinoid syndrome (CS) results from the secretion of bioactive amines by functional neuroendocrine tumors. The only FDA-approved agents to treat carcinoid syndrome symptoms (CSS)... read more here.
Keywords: somatostatin analogs; ssas use; carcinoid syndrome; analogs ssas ... See more keywords
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24043610
Abstract: Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the secretion of several substances, occurring in about 10–40% of patients with well-differentiated neuroendocrine tumors (NETs). The main signs and symptoms associated with carcinoid syndrome are… read more here.
Keywords: therapeutic strategies; preclinical models; carcinoid syndrome; future therapeutic ... See more keywords
The Role of Somatostatin Analogues in the Control of Diarrhea and Flushing as Markers of Carcinoid Syndrome: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm13020304
Abstract: Background: Somatostatin analogues (SSAs) are the cornerstone of treatment for carcinoid syndrome (CS)-related symptoms. The aim of this systematic review and meta-analysis is to evaluate the percentage of patients achieving partial (PR) or complete response… read more here.
Keywords: review meta; meta analysis; carcinoid syndrome; systematic review ... See more keywords
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceuticals"
DOI: 10.3390/ph14060539
Abstract: The carcinoid syndrome (CS) and hyperinsulinemic hypoglycemia (HH) represent two of the most common clinical syndromes associated with neuroendocrine neoplasms (NENs). The former is mainly related to the serotonin secretion by a small bowel NEN,… read more here.
Keywords: neuroendocrine neoplasms; carcinoid syndrome; management; associated neuroendocrine ... See more keywords
Staged treatment of carcinoid syndrome complicated with severe tricuspid regurgitation.
Sign Up to like & getrecommendations! Published in 2022 at "Kardiologia polska"
DOI: 10.33963/kp.a2022.0157
Abstract: We present a case of a 49-year-old male with symptomatic carcinoid heart disease (CHD), a rare complication of gastrointestinal carcinoid syndrome, which occurs in 1–2 per 100 000 adults per year. The 5-year survival rate… read more here.
Keywords: staged treatment; chd; carcinoid syndrome; treatment carcinoid ... See more keywords
Cases in a series of carcinoid syndrome and carcinoid heart disease.
Sign Up to like & getrecommendations! Published in 2018 at "Cardiovascular journal of Africa"
DOI: 10.5830/cvja-2018-040
Abstract: Although carcinoid syndrome is regarded as a rare entity, carcinoid patients with evidence of cardiac involvement show a markedly reduced survival time. Patients with advanced signs of right-sided heart failure represent a subgroup at particularly… read more here.
Keywords: heart; heart disease; carcinoid syndrome; syndrome carcinoid ... See more keywords